When we talk about breakthroughs in cancer research, most focus on the moment of discovery: a new therapy, a promising trial result, or a headline-grabbing study.
As complementary and alternative medicines continue to gain acceptance beyond the margins of cancer treatment, results from a recent study from Yale School of Medicine published in JAMA Network Open suggests that some patients using CAM with their mainstream therapy may, in fact, be substituting alternative medicine for allopathinc interventions.
